Related Experiment Videos
Identifying drug resistant cancer cells using microbubble well arrays
Qihui Pu1, Ryan Spooner1, Lisa A DeLouise2,3
1Department of Biomedical Engineering, University of Rochester, Rochester, NY, USA.
Abstract:
Drug resistance is a characteristic of tumor initiating cells that can give rise to metastatic disease. In this work we demonstrate the use of microbubble well arrays as a cell culture platform to enumerate and characterize drug resistant cells in a human derived tumorigenic squamous cell carcinoma cell line. The spherical architecture and compliant hydrophobic composition of the microbubble well favors single cell survival, clonal proliferation and formation of spheres that do not grow on standard tissue culture plastic and are resistant to cisplatin. Spheres form in isolation and in microbubble wells containing proliferating cells and to some degree they stain positive for common stem cell markers CD44 and CD133. Spheres are also observed in cellularized primary human tumors cultured in microbubble arrays. This proof-of-concept study illustrates the potential for microbubble array technology to enumerate cancer cells resistant to standard care drugs with the ability to test alternative drug combinations. This capability can be developed for designing patient specific treatment strategies. Recovery of drug-resistant cells will allow a more full characterization of their gene expression profile thereby expanding our fundamental knowledge and ability to develop new targets to fight metastatic disease.
Insights
Microbubble well arrays effectively identify and culture drug-resistant cancer cells, including stem cell markers. This technology aids in developing personalized cancer treatment strategies against metastatic disease.
Area of Science:
- Oncology
- Biotechnology
- Cell Biology
Background:
- Drug resistance in tumor-initiating cells drives metastatic disease.
- Standard cell culture methods may not adequately support the study of resistant cell populations.
Purpose of the Study:
- To evaluate microbubble well arrays as a platform for enumerating and characterizing drug-resistant cancer cells.
- To explore the potential of this technology for developing patient-specific treatment strategies.
Main Methods:
- Utilized microbubble well arrays for culturing a human squamous cell carcinoma line.
- Assessed cell survival, clonal proliferation, sphere formation, and expression of stem cell markers (CD44, CD133).
- Applied the platform to cellularized primary human tumors.
Main Results:
- Microbubble wells supported single-cell survival, clonal proliferation, and sphere formation resistant to cisplatin.
- Formed spheres showed positive staining for CD44 and CD133.
- Spheres were also observed in cultured primary human tumors.
Conclusions:
- Microbubble array technology can enumerate drug-resistant cancer cells and facilitate testing of drug combinations.
- This platform holds promise for designing personalized cancer therapies and understanding metastatic disease mechanisms.